ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006

NCI Advisors Approve Center Grants For Research On Health Disparities.

November 30, 2001

NCI Reports On Efforts To Prevent Cancer In Native Americans

August 13, 1999

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988

CTRC, UCLA Receive Gifts; NCCF Distributes Gold Pins.

March 24, 2000

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997